Position in XNCR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$970,709
-$933,855 QoQ
Shares Held
80,490
-35.3% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
515,343 | $29,956,888 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
845,118 | $29,908,726 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
419,773 | $25,337,498 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
647,836 | $24,105,977 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
95,335 | $23,335,147 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
1,051,465 | $22,985,024 | |
| 7 | MRNA |
Moderna, Inc.
|
274,820 | $19,245,644 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
649,027 | $17,510,748 |
All Filings in XNCR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $970,709 | 80,490 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,904,564 | 124,400 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,228,219 | 360,462 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,037,873 | 132,045 | Shares | Sole | 2025-08-14 | |
| 2024-03-31 | $1,546,068 | 69,863 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $217,395 | 10,240 | Shares | Sole | 2024-02-14 | |
| 2022-06-30 | $530,485 | 19,382 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $517,111 | 19,382 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||